Lamotrigine Starter Kits (generic)

About OWP Pharmaceuticals

OWP Pharmaceuticals operates as a mission-driven, for-profit pharmaceutical company with a direct humanitarian linkage. Its core commercial activity is the marketing of AB-rated generic lamotrigine starter kits (under the Subvenite brand and as plain generic), which are critical for the safe titration of this important neurological medication. The company's defining characteristic is its 'pharmaceutical social enterprise' model, where commercial profits are channeled to its affiliated public charity, ROW Foundation, to improve education, diagnosis, and treatment for neurological disorders in low-resource settings worldwide.

Therapeutic Areas

Other Epilepsy (adjunctive & monotherapy), Bipolar I Disorder (maintenance) Drugs